Article

The Role of Long-Chain Poly-Unsaturated Fatty Acids (LCPUFA) in Growth and Development

Dept of Neurology-Developmental Neurology, University Hospital Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Advances in Experimental Medicine and Biology (Impact Factor: 1.96). 02/2005; 569:80-94. DOI: 10.1007/1-4020-3535-7_13
Source: PubMed

ABSTRACT

It is debatable whether supplementation of infant formula with LCPUFA has an effect on infant growth and development. Up till now, there is little evidence of a negative effect on infant growth. A review of randomized controlled trials in term infants revealed that LCPUFA, in particularly supplementation with > or = 0.30% DHA, seems to have a beneficial effect on neurodevelopmental outcome up to 4 months of age. The studies could not demonstrate a consistent positive effect beyond that age. However, in the majority of studies neurodevelopmental outcome was assessed between 6 to 24 months, i.e. at an age where there is a 'latency' in the expression of minor neurological dysfunction. Thus it is possible that LCPUFA might have a long lasting beneficial effect on neurodevelopmental outcome at school-age and beyond. This hypothesis urgently needs testing.

Full-text preview

Available from: ernaehrungsdenkwerkstatt.de
  • [Show abstract] [Hide abstract]
    ABSTRACT: Docosahexaenoic acid (DHA) and arachidonic acid (ARA) are two long-chain polyunsaturated fatty acids (LCPUFAs) found naturally in human milk. DHA and ARA have been receiving increased attention from health care professionals and the public. Research suggests that DHA intake and status have a significant impact on visual and cognitive development in breastfed infants. For formula-fed infants, studies have shown mixed results from DHA or DHA plus ARA supplementation. There are several important differences among LCPUFA studies with term infants that may contribute to the differing results, including levels of LCPUFA added to the formula, variations in test methods, ages of infants evaluated, and sources of LCPUFA. Nevertheless, several expert groups recommend that infant formulas be supplemented with DHA and ARA. Recommendations for term infants for DHA and ARA range from 0.2 percent to 0.4 percent and from 0.35 percent to 0.7 percent of the fatty acids, respectively.
    No preview · Article · Jul 2007 · Neonatal network: NN
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nutritional and metabolic exposure during critical periods of early human development can have a long-term programming effect on health in adulthood. This is supported by evidence from epidemiological studies, numerous animal models and clinical intervention trials. An improved understanding of the mechanisms and effects of metabolic programming has the potential to contribute significantly to the prevention of some major health risks. Obesity and the metabolic syndrome, whose prevalences increase in almost all countries of the world, may have partly developmental origins. Collaboration of clinicians, epidemiologists and basic scientists in an EU funded research project on the relationship between early nutrition and later health (The EU Early Nutrition Programming Project, www.metabolic-programming.org) should provide further insights into metabolic programming and help to transfer scientific progress into clinical practice.
    No preview · Article · Sep 2006 · Early Human Development
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Homo sapiens has evolved on a diet rich in alpha-linolenic acid and long chain polyunsaturated fatty acids (LCP). We have, however, gradually changed our diet from about 10,000 years ago and accelerated this change from about 100 to 200 years ago. The many dietary changes, including lower intake of omega3-fatty acids, are related to 'typically Western' diseases. After a brief introduction in essential fatty acids (EFA), LCP and their functions, this contribution discusses our present low status of notably LCPomega3 in the context of our rapidly changing diet within an evolutionary short time frame. It then focuses on the consequences in pregnancy, lactation and neonatal nutrition, as illustrated by some recent data from our group. We discuss the concept of a 'relative' EFA/LCP deficiency in the fetus as the outcome of high transplacental glucose flux. This flux may in the fetus augment de novo synthesis of fatty acids, which not only dilutes transplacentally transported EFA/LCP, but also causes competition of de novo synthesized oleic acid with linoleic acid for delta-6 desaturation. Such conditions were encountered by us in mothers with high body mass indices, diabetes mellitus and preeclampsia. The unifying factor might be compromised glucose homeostasis. In search of the milk arachidonic acid (AA) and docosahexaenoic acid (DHA) contents of our African ancestors, we investigated women in Tanzania with high intakes of freshwater fish as only animal lipid source. These women had milk AA and DHA contents that were well above present recommendations for infant formulae. Both studies stimulate rethinking of 'optimal homeostasis'. Subtle signs of dysbalanced maternal glucose homeostasis may be important and observations from current Western societies may not provide us with an adequate basis for dietary recommendations.
    Full-text · Article · Oct 2006 · Prostaglandins Leukotrienes and Essential Fatty Acids
Show more